Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

T. Reece to Spinal Cord

This is a "connection" page, showing publications T. Reece has written about Spinal Cord.

 
Connection Strength
 
 
 
5.562
 
  1. Ghincea CV, Ikeno Y, Aftab M, Reece TB. Spinal Cord Protection for Thoracic Aortic Surgery: Bench to Bedside. Semin Thorac Cardiovasc Surg. 2019 Winter; 31(4):713-720.
    View in: PubMed
    Score: 0.535
  2. Yamanaka K, Eldeiry M, Aftab M, Mares J, Ryan TJ, Meng X, Weyant MJ, Cleveland JC, Fullerton DA, Reece TB. Optimized induction of beta common receptor enhances the neuroprotective function of erythropoietin in spinal cord ischemic injury. J Thorac Cardiovasc Surg. 2018 06; 155(6):2505-2516.
    View in: PubMed
    Score: 0.497
  3. Foley LS, Fullerton DA, Mares J, Sungelo M, Weyant MJ, Cleveland JC, Reece TB. Erythropoietin's Beta Common Receptor Mediates Neuroprotection in Spinal Cord Neurons. Ann Thorac Surg. 2017 Dec; 104(6):1909-1914.
    View in: PubMed
    Score: 0.488
  4. Foley LS, Reece TB. Advances in spinal cord protection for complex aortic repairs. J Thorac Cardiovasc Surg. 2016 Mar; 151(3):614-615.
    View in: PubMed
    Score: 0.426
  5. Reece T. Discussion. J Thorac Cardiovasc Surg. 2016 Feb; 151(2):517.
    View in: PubMed
    Score: 0.424
  6. Foley LS, Fullerton DA, Bennett DT, Freeman KA, Mares J, Bell MT, Cleveland JC, Weyant MJ, Meng X, Puskas F, Reece TB. Spinal Cord Ischemia-Reperfusion Injury Induces Erythropoietin Receptor Expression. Ann Thorac Surg. 2015 Jul; 100(1):41-6; discussion 46.
    View in: PubMed
    Score: 0.408
  7. Mares JM, Foley LS, Bell MT, Bennett DT, Freeman KA, Meng X, Weyant MJ, Cleveland JC, Fullerton DA, Puskas F, Reece TB. Erythropoietin activates the phosporylated cAMP [adenosine 3'5' cyclic monophosphate] response element-binding protein pathway and attenuates delayed paraplegia after ischemia-reperfusion injury. J Thorac Cardiovasc Surg. 2015 Mar; 149(3):920-4.
    View in: PubMed
    Score: 0.397
  8. Freeman KA, Fullerton DA, Foley LS, Bell MT, Cleveland JC, Weyant MJ, Mares J, Meng X, Puskas F, Reece TB. Spinal cord protection via alpha-2 agonist-mediated increase in glial cell-line-derived neurotrophic factor. J Thorac Cardiovasc Surg. 2015 Feb; 149(2):578-84; discussion 584-6.
    View in: PubMed
    Score: 0.395
  9. Bell MT, Puskas F, Bennett DT, Herson PS, Quillinan N, Fullerton DA, Reece TB. Dexmedetomidine, an a-2a adrenergic agonist, promotes ischemic tolerance in a murine model of spinal cord ischemia-reperfusion. J Thorac Cardiovasc Surg. 2014 Jan; 147(1):500-6.
    View in: PubMed
    Score: 0.366
  10. Bell MT, Agoston VA, Freeman KA, Puskas F, Herson PS, Mares J, Fullerton DA, Reece TB. Interruption of spinal cord microglial signaling by alpha-2 agonist dexmedetomidine in a murine model of delayed paraplegia. J Vasc Surg. 2014 Apr; 59(4):1090-7.
    View in: PubMed
    Score: 0.362
  11. Reece TB, Tribble CG, Okonkwo DO, Davis JD, Maxey TS, Gazoni LM, Linden J, Kron IL, Kern JA. Early adenosine receptor activation ameliorates spinal cord reperfusion injury. J Cardiovasc Med (Hagerstown). 2008 Apr; 9(4):363-7.
    View in: PubMed
    Score: 0.251
  12. Reece TB, Kron IL, Okonkwo DO, Laurent JJ, Tache-Leon C, Maxey TS, Ellman PI, Linden J, Tribble CG, Kern JA. Functional and cytoarchitectural spinal cord protection by ATL-146e after ischemia/reperfusion is mediated by adenosine receptor agonism. J Vasc Surg. 2006 Aug; 44(2):392-7.
    View in: PubMed
    Score: 0.224
  13. Aftab M, Reece TB. Commentary: Direct spinal cord perfusion: You need it when you need it. J Thorac Cardiovasc Surg. 2019 10; 158(4):e131-e132.
    View in: PubMed
    Score: 0.135
  14. Aftab M, Reece TB. Commentary: NO matter what you call it, "conditioning" the spinal cord preventing paraplegia is worthwhile. J Thorac Cardiovasc Surg. 2020 03; 159(3):825-826.
    View in: PubMed
    Score: 0.135
  15. Yamanaka K, Eldeiry M, Aftab M, Ryan TJ, Meng X, Weyant MJ, Fullerton DA, Reece TB. Synergetic Induction of NGF With Diazoxide and Erythropoietin Attenuates Spinal Cord Ischemic Injury. J Surg Res. 2019 01; 233:124-131.
    View in: PubMed
    Score: 0.129
  16. Eldeiry M, Yamanaka K, Reece TB, Aftab M. Spinal Cord Neurons Isolation and Culture from Neonatal Mice. J Vis Exp. 2017 07 11; (125).
    View in: PubMed
    Score: 0.119
  17. Freeman KA, Puskas F, Bell MT, Mares JM, Foley LS, Weyant MJ, Cleveland JC, Fullerton DA, Meng X, Herson PS, Reece TB. Alpha-2 agonist attenuates ischemic injury in spinal cord neurons. J Surg Res. 2015 May 01; 195(1):21-8.
    View in: PubMed
    Score: 0.100
  18. Smith PD, Puskas F, Fullerton DA, Meng X, Cho D, Cleveland JC, Weyant MJ, Reece TB. Attenuation of spinal cord ischemia and reperfusion injury by erythropoietin. J Thorac Cardiovasc Surg. 2011 Jan; 141(1):256-60.
    View in: PubMed
    Score: 0.076
  19. Reece TB, Okonkwo DO, Ellman PI, Maxey TS, Tache-Leon C, Warren PS, Laurent JJ, Linden J, Kron IL, Tribble CG, Kern JA. Comparison of systemic and retrograde delivery of adenosine A2A agonist for attenuation of spinal cord injury after thoracic aortic cross-clamping. Ann Thorac Surg. 2006 Mar; 81(3):902-9.
    View in: PubMed
    Score: 0.054
  20. MacGillivray TE, Gleason TG, Patel HJ, Aldea GS, Bavaria JE, Beaver TM, Chen EP, Czerny M, Estrera AL, Firestone S, Fischbein MP, Hughes GC, Hui DS, Kissoon K, Lawton JS, Pacini D, Reece TB, Roselli EE, Stulak J. The Society of Thoracic Surgeons/American Association for Thoracic Surgery clinical practice guidelines on the management of type B aortic dissection. J Thorac Cardiovasc Surg. 2022 Apr; 163(4):1231-1249.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)